GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Tue, 23 Apr 2024

CCXI Predictions History

4 years ago
JS predicted that CCXI for 2020-02-04 is going $46.24 (2.17%)

4 years ago
Brandon Nelson predicted that CCXI for 2020-02-04 is going

Rank:

4 years ago
DavidStroehmann137669 predicted that CCXI for 2020-02-04 is going

Rank:

4 years ago
Donnie Hendrix predicted that CCXI for 2019-10-31 is going

Rank:

4 years ago
GoldenNugget predicted that CCXI for 2019-05-07 is going $12.84 (-4.22%)

4 years ago
GoldenNugget predicted that CCXI for 2019-05-06 is going $12.70 (-1.74%)

4 years ago
NameNotImportant predicted that CCXI for 2019-04-29 is going $13.27 (1.14%)

5 years ago
NameNotImportant predicted that CCXI for 2019-04-23 is going $12.72 (-0.47%)

5 years ago
NameNotImportant predicted that CCXI for 2019-04-22 is going $11.87 (-2.14%)

6 years ago
Andrew.Christian-Taylor.Camardella.21790 predicted that CCXI for 2018-03-14 is going $12.94 (1.17%)

Rank:
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT